Mountain House, CA, United States of America

Sri Paladugu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Roche Sequencing Solutions, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sri Paladugu. Retrieved from https://idiyas.com/inventor/sri-paladugu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sri Paladugu: Innovator in Immunology

Introduction

Sri Paladugu is a notable inventor based in Mountain House, CA (US). He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the identification of antigen epitopes and immune sequences that recognize specific antigens.

Latest Patents

Sri Paladugu holds a patent for the "Identification of antigen epitopes and immune sequences recognizing the antigens." This patent includes methods, compositions, and reaction mixtures for identifying a T cell receptor (TCR) and an epitope peptide that specifically binds to the TCR. Additionally, it provides methods for identifying multiple T cell receptors and corresponding epitope peptides in a highly parallel manner. He has 1 patent to his name.

Career Highlights

Sri Paladugu is currently employed at Roche Sequencing Solutions, Inc., where he continues to advance his research in immunology. His work has the potential to impact various applications in medical science and therapeutic development.

Collaborations

One of his notable coworkers is Jan Berka, with whom he collaborates on various projects within the company.

Conclusion

Sri Paladugu's innovative work in identifying antigen epitopes and immune sequences showcases his dedication to advancing immunological research. His contributions are valuable to the scientific community and have the potential to lead to significant advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…